Sesen Bio Inc reports results for the quarter ended in September - Earnings Summary

Carisma Therapeutics

08/11/2021 14:31

* Sesen Bio Inc  SESN.OQ  reported quarterly adjusted earnings
of 36 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 7 cents per share.
* Reported revenue was zero​;  analysts expected $533.33
thousand. 
* Sesen Bio Inc's reported EPS for the quarter was 36 cents​.
* The mean earnings estimate of analysts had fallen by
about 16.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sesen Bio Inc shares had risen by 48.8% this quarter and
lost 12.6% so far this year.
* The company reported quarterly net income of $71.62 million.
* Wall Street's median 12-month price target for Sesen Bio Inc
is $2.25 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated